IFNG and cancer: The intratumoral expression of IFNg has the potential to reprogram the TME by decreasing the populations of intratumoral T-regs and myeloid cells, as well as by activating the antitumor T cell subsets, which is enhanced by the antiproliferative qualities of IFNg in synergy with the induction of apoptosis in SFV-infected cancer cells.